Street Talk: Summer No Picnic for Investors - At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going - BioPharm

ADVERTISEMENT

Street Talk: Summer No Picnic for Investors
At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going


BioPharm International
Volume 21, Issue 9

IT EXPLAINS A LOT

What to do? Sitting this one out and putting your money into treasuries seems like good common sense. And know that this crisis, too, shall pass. Capital markets have a way of dealing with excess, like we saw with the dotcoms in 1999 and 2000, and with the subprime credit markets today. The market tends to square things away pretty efficiently, even though a lot of people get hurt.

The name of the game is not to be one of those people.

Celebrity author and business/finance commentator for CNN and Fox News, Brian O'Connell has written for The Wall Street Journal and Newsweek, Doylestown, PA, 267.880.3144,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here